Results 191 to 200 of about 92,598 (347)

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

A Review of Blood Transfusion Requests in Rl Jalappa Hospital and Research Centre for Blood and Blood Components

, 2012
Venkatachalapathy TS, Subhashish Das
openalex   +1 more source

Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support

ESC Heart Failure, EarlyView.
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau, Laura Coyle, Rachel Pedersen, Colleen Gallagher, Nicole Graney, Lisa Kukla, Robin Paliga, Gregory P. Macaluso, Sunil Pauwaa, William G. Cotts, Patroklos S. Pappas, Antone J. Tatooles, Nikhil Narang   +12 more
wiley   +1 more source

Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist device

ESC Heart Failure, EarlyView.
Abstract Aims Donation after circulatory death (DCD) has emerged as a strategy to increase the donor pool for heart transplantation (HT). Left ventricular assist device (LVAD) patients represent a discrete and unique population. We sought to explore the early outcomes of DCD‐HT compared with donation after brain death (DBD) HT in LVAD patients. Methods
Aris Karatasakis, Edwin Grajeda Silvestri, Gatha G. Nair, Benjamin Zuniga, Song Li, Claudius Mahr, Richard K. Cheng, April S. Stempien‐Otero, Ioannis Dimarakis, Maziar Khorsandi, Jay D. Pal, Jorge R. Kizer, Marc A. Simon, Claudio A. Bravo   +13 more
wiley   +1 more source

Aprotinin in orthotopic liver transplantation [PDF]

, 1993
Bechstein, W. O., Blumhardt, G., Gerlach, H., Himmelreich, G., Jochum, Marianne, Keck, H., Neuhaus, P., Riess, H., Roissaint, R.   +8 more
core   +1 more source

Prognostic value of longitudinal strain relative apical sparing in severe aortic stenosis patients undergoing TAVR

ESC Heart Failure, EarlyView.
Abstract Aims This study evaluated the prognostic value of the relative apical sparing pattern (RASP) of longitudinal strain (LS) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) and investigated whether its combination with pre‐procedural biomarkers enhances risk stratification.
Dan Liu, Kai Hu, Vera Schimpf, Victoria Sokalski, Friederike Hermann, Björn Daniel Lengenfelder, Georg Ertl, Stefan Frantz, Peter Nordbeck   +8 more
wiley   +1 more source

Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial.

JAMA, 2019
Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussières J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K, FIBRES Research Group.   +22 more
europepmc   +1 more source

Blood, Blessings and Technology in India [PDF]

, 2006
Copeman, Jacob
core  

STUDY OF THE RATIO OF CROSS-MATCHING TO TRANSFUSION OF BLOOD OR BLOOD COMPONENT, I.E. PACKED RED BLOOD CORPUSCLES TO DEVELOP GOOD PRACTICES FOR THE UTILISATION OF BLOOD

, 2017
Kanika Bansal, Rakesh Kakkar
openalex   +1 more source

Rationale and design of the randomized ‘early ventricular assist device’—Trial (VAD‐DZHK3)

ESC Heart Failure, EarlyView.
The VAD‐DZHK3 trial is a randomised controlled study evaluating whether elective LVAD implantation improves outcomes in end‐stage heart failure (HF) patients listed for heart transplantation compared with delayed implantation after clinical deterioration.
Christoph Knosalla, Gloria Färber, Andreas J. Rieth, Rolf Wachter, Marius Placzek, Wolfgang Albert, Gerd Hasenfuß, Volkmar Falk, Tim Friede, for the VAD‐DZHK3 Investigators   +9 more
wiley   +1 more source